CF
WST icon

Centaurus Financial’s West Pharmaceutical WST Stock Holding History

Centaurus Financial’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-295
Closed -$104K – 861
2023
Q4 		$104K Sell
295
-330
-53% -$117K 0.01% 749
2023
Q3 		$235K Hold
625
– – 0.02% 519
2023
Q2 		$239K Sell
625
-22
-3% -$7.86K 0.02% 518
2023
Q1 		$224K Buy
647
+22
+4% +$6.43K 0.02% 631
2022
Q4 		$147K Buy
+625
New +$148K 0.01% 684
2022
Q3 		– Sell
-397
Closed -$120K – 903
2022
Q2 		$120K Sell
397
-11
-3% -$3.58K 0.01% 753
2022
Q1 		$168K Buy
408
+163
+67% +$63.8K 0.01% 715
2021
Q4 		$115K Buy
+245
New +$105K 0.01% 855

Other funds holding WST

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
APG Asset Management
APG Asset Management Amsterdam, Netherlands $40.7B AUM 39.97% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return

Centaurus Financial's WST Position: Q1 2024 in Review

Centaurus Financial sold out of West Pharmaceutical (WST) in Q1 2024, closing a stake of 295 shares — an estimated $104K sold.

Centaurus Financial first reported a position in WST in Q4 2021 and held it in 8 quarters. The position peaked at $239K in Q2 2023. 778 funds tracked by Wall St. Rank hold WST as of Q1 2024.

  • Centaurus Financial reported no remaining West Pharmaceutical position as of Q1 2024 after selling out during the quarter.
  • Centaurus Financial sold 295 West Pharmaceutical shares in Q1 2024, an estimated $104K.
  • Centaurus Financial first reported a position in West Pharmaceutical in Q4 2021 and held it in 8 quarters.
  • Centaurus Financial's West Pharmaceutical position peaked at $239K in Q2 2023.
  • 778 funds tracked by Wall St. Rank held West Pharmaceutical as of Q1 2024.

Based on Centaurus Financial's 13F filing for Q1 2024, filed 14 May 2024.